The Daily: 'Can We Reverse Aging?' Review

The Daily, the acclaimed daily news podcast from The New York Times on Apple Podcasts, tackles one of humanity's oldest obsessions in "Can We Reverse Aging?"—a 29.9-minute dive into the science of longevity and cellular rejuvenation. Host Rachel Abrams speaks with colleague Dominus about the latest breakthroughs in aging research, where billions are flowing into treatments and therapies promising to restore youth. The episode explores fascinating territory: how embryos naturally "reset" the aging markers they inherit, and how researcher Shinya Yamanaka discovered genes that could revert aged cells back to embryonic form—a discovery that earned him the Nobel Prize. This is The Daily doing what it does best: taking a complex scientific topic that matters to everyday people (who doesn't want to live longer and healthier?) and unpacking it through interviews with experts who understand the money, the hype, and the actual science behind the longevity boom. The episode is tightly produced, moves at a good pace, and feels genuinely informative without overloading you with jargon or oversimplification. You'll finish understanding what cellular rejuvenation is, why it works in theory, and why billionaires and biotech startups are betting billions on it becoming reality. Score: 8.0/10—a smart, accessible exploration of cutting-edge science that lands somewhere between "did not know this existed" and "wow, that's actually close to working."

What Makes The Daily 'Can We Reverse Aging?' Work

The heart of this episode is the deceptively simple question: why is a baby born young? It sounds obvious until Dominus explains that sperm and eggs actually carry aging markers from their parents—and yet somehow, embryos shed those markers after fertilization and start at "ground zero" for aging. That biological reset is the core principle behind cellular rejuvenation, and once you understand that mechanism, the entire scientific quest snaps into focus. It's the kind of foundational explanation that makes complex science click.

The episode's interviews are grounded in real, documented progress. Yamanaka's Nobel Prize-winning discovery (applying embryo-expressed genes to aged cells to revert them) is presented not as science fiction but as established fact from two decades ago. When the hosts mention that a researcher actually did this in 2006 and the scientific establishment recognized it enough to award the Nobel Prize, suddenly the field doesn't feel like venture-backed fantasy—it feels like legitimate science with real momentum behind it. The conversation doesn't pretend we're close to Fountain of Youth shots for sale at the pharmacy, but it's honest about how much traction exists in the field.

"From The New York Times, I'm Rachel Abrams, and this is The Daily On Sunday."

The production keeps things moving—no tangents, no filler, no 15-minute digression about a billionaire's personal wellness routine. The hosts speak clearly about dense topics (cellular age markers, epigenetic clocks, the difference between slowing aging and reversing it) in a way that's accessible without being dumbed down. That balance is harder than it sounds, and The Daily nails it here. By the end, you understand not just what cellular rejuvenation is, but why it matters and why it's captured billions in funding. You're left wanting to know more about the ethics of unequal access to life extension, or whether we should be solving aging at all, but that's genuinely material for a second episode, not a flaw with this one.

The Ad Load on The Daily: 2 Ads, 1.3 Minutes

This episode carries 2 ads running 1.3 minutes total—just 4.2% of the episode. The detected sponsors are NYT Songwriters and Crossplay. That's a genuinely light load for modern podcasting and won't pull you out of the narrative flow mid-conversation. If you listen to The Daily regularly and want to skip these spots automatically while you listen, skip The Daily ads automatically on PodSkip.

The Daily Review: Is 'Can We Reverse Aging?' Worth Listening?

Yes, 8.0/10. This is a well-researched, well-paced episode on a topic that genuinely affects everyone—aging and longevity science are mainstream enough to matter, weird enough to be fascinating, and grounded enough in real breakthroughs that you'll actually learn something concrete. The only minor critique is that the episode doesn't dig into the ethical implications of a life-extension technology that will inevitably be expensive and unequally accessible first, but that's material for a separate segment. On what it attempts, it succeeds cleanly and with style.

FAQ: The Daily 'Can We Reverse Aging?' Review

What is cellular rejuvenation and can it actually reverse aging?

Cellular rejuvenation is the idea of making aged cells function like younger versions of themselves by applying genes highly expressed in embryos. Yes, it's been demonstrated in lab settings—Shinya Yamanaka showed in 2006 that this works on mouse cells and won the Nobel Prize for it—but human therapies are still in research and early development phases. The episode handles this distinction honestly: real progress, but not ready for clinics yet. The scientists being interviewed are careful to separate what's possible in theory from what's available as a treatment today.

How many ads are in this episode of The Daily?

The Daily "Can We Reverse Aging?" has 2 ads totaling 1.3 minutes, or 4.2% of the episode. Detected sponsors are NYT Songwriters and Crossplay. Most Daily episodes run light on ads like this, so if you're a regular listener, this is typical for the show. The ad load is one of the lighter ones in daily news podcasting.

Is The Daily a good podcast for science and research topics?

The Daily consistently breaks down complex topics—science, policy, culture—in ways that are accessible and rigorous. If you enjoyed this episode on longevity, you might also like The Daily: 'Lessons From the Hantavirus' Review or The Daily: 'Graham Platner's Plan' Review for similar reporting depth and production quality.

▶ See all The Daily episodes on PodSkip →